Goldman’s Top Strategist Sees a Dangerous Amount of Leverage Piling Up

Photo of Omor Ibne Ehsan
By Omor Ibne Ehsan Published

Quick Read

  • XLV has surged 6% in a month versus SPY's 2%, and Snider recommends health care to balance crowded, leveraged AI exposure.

  • Snider warns simultaneous leverage across retail, hedge funds, and leveraged ETFs is building dangerously as SPY gains 10% and QQQ 18% year to date.

  • The headline S&P 500 earnings growth bar sits at 22%, but the median company only needs to clear 9%, creating broad upside surprise potential.

  • Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

Goldman’s Top Strategist Sees a Dangerous Amount of Leverage Piling Up

© PeopleImages / Shutterstock.com

Ben Snider, Chief U.S. Equity Strategist at Goldman Sachs, went on CNBC to say something that should register with anyone who has been happily riding this market higher. The character of this market is shifting midyear, and the driver is a substantial increase in a substantial increase in leverage across investor types: retail margin debt, hedge-fund leverage, and leveraged ETFs. With the S&P 500 up 9.6% year to date and the Nasdaq-100 up 16%, the complacency reading is doing exactly what complacency readings do before the next air pocket.

The Leverage Warning

Leverage is a crowbar. It lets you move something heavier than you could move on your own, and it does the same thing on the way back down when the object lands on your foot. When Snider says leverage is up across retail, hedge funds, and leveraged ETF assets, he is saying the crowbar is getting longer for all three groups at the same time.

That matters because the VIX at 15.81 sits in the 22.6th percentile of its one-year range, which is precisely the environment where investors talk themselves into more risk on the belief that volatility is contained. It is also the environment in which the March 27, 2026 spike to 31.05 was born, back when the VIX stayed above 20 from March 6 through April 9. The gauge decays slowly and spikes fast. Leverage does the same thing in reverse.

Why This Means More Volatility

Snider is already seeing the fingerprints in price action, particularly in the momentum factor and semiconductors. That is the mechanical part of the story. When positioning gets crowded and leveraged into the same names, small moves in the underlying trigger larger moves in the derivatives, which trigger forced buying or selling from leveraged ETFs rebalancing at the close, which feeds back into the underlying.

The rate backdrop is not helping. The 10-year Treasury yield sits at 4.49%, in the 93.2nd percentile of its one-year range, and the 10-year minus 2-year spread has compressed to 0.35%, in the 4th percentile. Expensive leverage plus a flattening curve is not the backdrop where you want to be maximum long the most crowded factor.

The Rotation Into Health Care

Snider’s playbook is not calling for AI capitulation; fundamentals in the AI complex remain strong. He wants investors to balance AI exposure with less-correlated areas like health care, which he described as having a quiet, solid run. The numbers agree with him. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is up 6.31% over the past month versus the SPDR S&P 500 ETF Trust‘s (NYSEARCA:SPY) 1.86%, and up 21.61% over the past year.

Snider also thinks the AI infrastructure trade may lose near-term momentum because capex guidance upgrades tend to land at the end and beginning of the calendar year, not midyear, so the big upward revisions that juiced last quarter are probably not repeating in Q2 prints.

If you want the deeper reading on why diversification within the boom matters, our 7 Stocks Powering the AI Boom (That Aren’t Chipmakers) report walks through the enabler names that sit outside the crowded semi trade. Goldman’s own view on this concentration risk is laid out in its 2026 Investment Outlook.

The Median Company’s Earnings Bar Is Lower Than the Headline

The number that matters most is the one you will not see in the CNBC chyron. Consensus S&P 500 earnings growth is 22%, the highest bar since 2021, but that figure is skewed by mega-caps. Snider prefers the median company’s growth number, which is 9%, down from 13% last quarter. That is a materially more beatable bar for the other 493 stocks.

So if you are trying to reconcile a scary headline expectation with a market that keeps grinding higher, this is the reconciliation. The index has to clear a hurdle only the top ten names can clear. Everyone else has room to surprise. Which, if Snider is right about leverage, is exactly the asymmetry you want to own into a volatility regime shift.

 

Contact [email protected] for any questions or corrections.

Photo of Omor Ibne Ehsan
About the Author Omor Ibne Ehsan →

Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

OXY Vol: 6,668,535
CBOE Vol: 988,424
DVN Vol: 11,501,181
CTSH Vol: 6,840,164
GDDY Vol: 1,118,052

Top Losing Stocks

TER Vol: 4,454,467
INTC Vol: 116,186,584
GNRC Vol: 1,373,908
WDC Vol: 6,513,909
CTRA Vol: 73,319,495